Stephen Robb
CIK 1304159 · View on SEC EDGAR ↗
First SEC filing: Feb. 11, 2020 · Latest: Feb. 11, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2015 | CLX | S 10b5-1 | 27,596 | $121.98 | $3,366,160 | 24,006 Direct | -53.48% | Disposed | -11.5% (price as of 2026-08-19) |
| Nov. 17, 2015 | CLX | S 10b5-1 | 2,900 | $122.40 | $354,960 | 51,602 Direct | -5.32% | Disposed | -11.8% (price as of 2026-08-19) |
| Oct. 6, 2015 | CLX | S 10b5-1 | 19,125 | $119.00 | $2,275,875 | 22,035 Direct | -46.47% | Disposed | -9.3% (price as of 2026-08-19) |
| Sept. 25, 2015 | CLX | S 10b5-1 | 21,020 | $115.00 | $2,417,300 | 20,910 Direct | -50.13% | Disposed | -6.2% (price as of 2026-08-19) |
| Sept. 18, 2015 | CLX | S 10b5-1 | 8,500 | $113.84 | $967,640 | 19,500 Direct | -30.36% | Disposed | -5.2% (price as of 2026-08-19) |
| Aug. 4, 2015 | CLX | S 10b5-1 | 15,849 | $115.00 | $1,822,635 | 5,909 Direct | -72.84% | Disposed | -6.2% (price as of 2026-08-19) |
| Aug. 3, 2015 | CLX | S 10b5-1 | 21,497 | $115.00 | $2,472,155 | 3,613 Direct | -85.61% | Disposed | -6.2% (price as of 2026-08-19) |
| March 16, 2015 | CLX | S 10b5-1 | 23,679 | $109.46 | $2,591,903 | 3,445 Direct | -87.30% | Disposed | -1.4% (price as of 2026-08-19) |
| March 16, 2015 | CLX | S 10b5-1 | 1,600 | $109.96 | $175,936 | 27,124 Direct | -5.57% | Disposed | -1.9% (price as of 2026-08-19) |
| April 16, 2013 | CLX | S 10b5-1 | 5,100 | $89.05 | $454,155 | 5,868 Direct | -46.50% | Disposed | 21.2% (price as of 2026-08-19) |
| April 12, 2013 | CLX | S 10b5-1 | 2,000 | $89.06 | $178,120 | 4,374 Direct | -31.38% | Disposed | 21.2% (price as of 2026-08-19) |
| April 3, 2013 | CLX | S 10b5-1 | 402 | $89.21 | $35,862 | 3,788 Direct | -9.59% | Disposed | 21.0% (price as of 2026-08-19) |
| Feb. 1, 2013 | CLX | S 10b5-1 | 8,781 | $79.29 | $696,245 | 3,670 Direct | -70.52% | Disposed | 36.1% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 7, 2020 | TBI | Deferred Stock Award | Common Stock (9,626) | — | — | 9,626 | Acquired |
| Feb. 11, 2019 | TBI | Deferred Stock Award | Common Stock (9,383) | — | — | 9,383 | Acquired |
| Feb. 9, 2018 | TBI | Deferred Stock Award | Common Stock (8,005) | — | — | 8,005 | Acquired |
| Sept. 12, 2017 | CLX | Stock Option (Right to Buy) | Common Stock (49,130) | $135.57 | Sept. 12, 2027 | 49,130 | Acquired |
| Feb. 10, 2017 | TBI | Deferred Stock Award | Common Stock (8,532) | — | — | 8,532 | Acquired |
| Sept. 13, 2016 | CLX | Stock Option (Right to Buy) | Common Stock (50,950) | $123.09 | Sept. 13, 2026 | 50,950 | Acquired |
| April 1, 2016 | TBI | Deferred Stock Award | Common Stock (4,374) | — | — | 4,374 | Acquired |
| Nov. 17, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (32,467) | $64.96 | Nov. 17, 2021 | 32,467 | Disposed |
| Oct. 6, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (20,250) | $68.15 | Sept. 13, 2021 | 20,250 | Disposed |
| Sept. 25, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (22,240) | $66.48 | Sept. 14, 2020 | 22,240 | Disposed |
| Sept. 15, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (41,830) | $111.60 | Sept. 15, 2025 | 41,830 | Acquired |
| Aug. 4, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (16,887) | $63.95 | Sept. 16, 2018 | 16,887 | Disposed |
| Aug. 4, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (1,258) | $57.25 | Sept. 15, 2019 | 1,258 | Disposed |
| Aug. 3, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (1,093) | $63.95 | Sept. 16, 2018 | 1,093 | Disposed |
| Aug. 3, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (20,572) | $57.25 | Sept. 15, 2019 | 20,572 | Disposed |
| March 16, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (11,400) | $61.51 | Sept. 19, 2016 | 11,400 | Disposed |
| March 16, 2015 | CLX | Stock Option (Right to Buy) | Common Stock (15,400) | $61.16 | Sept. 18, 2017 | 15,400 | Disposed |
| Sept. 17, 2014 | CLX | Stock Option (Right to Buy) | Common Stock (57,290) | $89.82 | Sept. 17, 2024 | 57,290 | Acquired |
| Sept. 17, 2013 | CLX | Stock Option (Right to Buy) | Common Stock (40,980) | $84.45 | Sept. 17, 2023 | 40,980 | Acquired |
| April 16, 2013 | CLX | Stock Option (Right to Buy) | Common Stock (6,594) | $57.00 | Sept. 21, 2015 | 6,594 | Disposed |
| April 12, 2013 | CLX | Stock Option (Right to Buy) | Common Stock (2,586) | $57.00 | Sept. 21, 2015 | 2,586 | Disposed |
| April 3, 2013 | CLX | Stock Option (Right to Buy) | Common Stock (520) | $57.00 | Sept. 21, 2015 | 520 | Disposed |
| Feb. 1, 2013 | CLX | Stock Option (Right to Buy) | Common Stock (11,000) | $53.88 | Sept. 15, 2014 | 11,000 | Disposed |
| Sept. 11, 2012 | CLX | Stock Option (Right to Buy) | Common Stock (54,600) | $72.11 | Sept. 11, 2022 | 54,600 | Acquired |
| Nov. 17, 2011 | CLX | Stock Option (Right to Buy) | Common Stock (32,467) | $64.96 | Nov. 17, 2021 | 32,467 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 18 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 19, 2015 | CLX | Common Stock | — | Direct |
| Aug. 19, 2015 | CLX | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| Oct. 13, 2011 | CLX | Common Stock | 3,339 | Indirect |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (11,000) | 11,000 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (9,700) | 9,700 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (21,830) | 21,830 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (15,400) | 15,400 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (11,400) | 11,400 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (17,980) | 17,980 | Direct |
| Oct. 13, 2011 | CLX | Stock Option (Right to Buy)→ Common Stock (22,240) | 22,240 | Direct |
| Oct. 8, 2004 | CLX | Common Stock | 7,247 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 00AD→ Common Stock (5,000) | 5,000 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 00AN→ Common Stock (6,429) | 6,429 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 01AK→ Common Stock (7,740) | 7,740 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 02AT→ Common Stock (5,055) | 5,055 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 03BE→ Common Stock (5,720) | 5,720 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 04CQ→ Common Stock (11,000) | 11,000 | Direct |
| Oct. 8, 2004 | CLX | Stock Option (Right to Buy) - 99N/2→ Common Stock (7,800) | 7,800 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $484,231 | — | — | — | $309,210 | $683,981 | $186,161 | $3,163,500 |
| 2016 | $576,846 | — | — | — | $945,010 | $366,586 | $224,752 | $3,213,447 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.